Banawan, Jushfer .

HRN: 26-20-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2024
CEFUROXIME 750MG (VIAL)
11/10/2024
11/17/2024
IV
335
Q8
PCAP C
Waiting Final Action 
07/26/2025
CEFUROXIME 750MG (VIAL)
07/26/2025
08/02/2025
IV
320mg
Q8H
PCAP C
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: